<DOC>
	<DOCNO>NCT00147862</DOCNO>
	<brief_summary>To Study whether infusion Tranexamic Acid ( synthetic antifibrinolytic agent ) reduce blood loss head neck surgery .</brief_summary>
	<brief_title>Does Tranexamic Acid Administration Reduce Blood Loss During Head Neck Surgery ?</brief_title>
	<detailed_description>Blood blood product precious resource . Administration blood blood product carry risk postoperative bacterial infection1 increase recurrence rate certain type cancer . Lower transfusion trigger , preoperative autologous blood donation without erythropoietin , intraoperative red blood cell salvage , regional anesthesia , control hypotension , antifibrinolytic agent useful mean decrease need allogenic transfusion . Tranexamic acid , synthetic antifibrinolytic agent bind lysine bind site plasminogen block bind plasminogen fibrin surface . Thus plasminogen activation prevent fibrinolysis delayed . It use reduce blood loss coronary revascularization , orthotopic liver transplantation4 , scoliosis correction surgery orthopedic procedure . The use tranexamic acid intraoperatively show reduce blood loss 25 - 40 % various study . The primary concern administer antifibrinolytic drug potential increase incidence thromboembolic event . A common misconception synthetic antifibrinolytic drug increase blood clot . The drug alter blood clotting , rather slow dissolution blood clot . There data utility tranexamic acid reduce blood loss head &amp; neck cancer surgery . We want compare Tranexamic Acid infusion Saline ( Placebo ) infusion see whether Tranexamic ACid Administration reduce blood loss . Reduction transfusion requirement lead reduce cost possible reduction complication blood transfusion .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>All eligible previously untreated patient resectable squamous cell carcinoma oral cavity Undergoing composite resection mandible along neck dissection require reconstructive procedure form pedicled flap . Patients agree participate give informed consent . Coagulopathy form cause ( Abnormal coagulogram prothrombin time ( PT ) &gt; 18 second partial prothrombin time ( PTT ) &gt; 50 second , recent ( &lt; 5 day ) acetylsalicylic acid ingestion , anticoagulant therapy ( heparin , 4 hour preoperative warfarin , 3 day preoperatively ) . Preexisting renal dysfunction ( serum creatinine 200 mmol/L ) , Known allergy tranexamic acid , Peripheral vascular disease .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Antifibrinolytic Agents</keyword>
	<keyword>Head Neck Neoplasms</keyword>
	<keyword>Thromboelastography</keyword>
</DOC>